Calamos Advisors
INSP icon

Calamos Advisors’s Inspire Medical Systems INSP Stock Holding History

Calamos Advisors’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,483
Closed -$1.93M – 987
2023
Q4 		$1.93M Buy
+9,483
New +$1.54M 0.01% 609
2023
Q3 		– Sell
-19,982
Closed -$6.49M – 963
2023
Q2 		$6.49M Buy
19,982
+2,723
+16% +$778K 0.03% 527
2023
Q1 		$4.04M Buy
17,259
+2,094
+14% +$529K 0.02% 670
2022
Q4 		$3.82M Buy
15,165
+5,411
+55% +$1.15M 0.02% 712
2022
Q3 		$1.73M Sell
9,754
-23,272
-70% -$4.68M 0.01% 889
2022
Q2 		$6.03M Sell
33,026
-1,646
-5% -$328K 0.03% 644
2022
Q1 		$8.9M Sell
34,672
-4,777
-12% -$1.09M 0.03% 553
2021
Q4 		$9.08M Buy
39,449
+1,722
+5% +$420K 0.03% 527
2021
Q3 		$8.79M Sell
37,727
-2,703
-7% -$564K 0.04% 464
2021
Q2 		$7.81M Sell
40,430
-2,329
-5% -$462K 0.04% 467
2021
Q1 		$8.85M Sell
42,759
-1,421
-3% -$302K 0.05% 368
2020
Q4 		$8.31M Sell
44,180
-20,497
-32% -$3.35M 0.05% 370
2020
Q3 		$8.35M Sell
64,677
-1,490
-2% -$164K 0.05% 345
2020
Q2 		$5.76M Buy
66,167
+4,532
+7% +$348K 0.04% 416
2020
Q1 		$3.71M Sell
61,635
-89
-0.1% -$6.59K 0.03% 454
2019
Q4 		$4.58M Sell
61,724
-21,736
-26% -$1.4M 0.02% 534
2019
Q3 		$5.09M Buy
83,460
+26,612
+47% +$1.75M 0.03% 508
2019
Q2 		$3.45M Buy
+56,848
New +$3.06M 0.02% 572

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Calamos Advisors's INSP Position: Q1 2024 in Review

Calamos Advisors sold out of Inspire Medical Systems (INSP) in Q1 2024, closing a stake of 9,483 shares — an estimated $1.93M sold.

Calamos Advisors first reported a position in INSP in Q2 2019 and held it in 18 quarters. The position peaked at $9.08M in Q4 2021. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

  • Calamos Advisors reported no remaining Inspire Medical Systems position as of Q1 2024 after selling out during the quarter.
  • Calamos Advisors sold 9,483 Inspire Medical Systems shares in Q1 2024, an estimated $1.93M.
  • Calamos Advisors first reported a position in Inspire Medical Systems in Q2 2019 and held it in 18 quarters.
  • Calamos Advisors's Inspire Medical Systems position peaked at $9.08M in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Calamos Advisors's 13F filing for Q1 2024, filed 8 May 2024.